MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.

Agirre-Lizaso A, Huici-Izagirre M, O'Rourke CJ, Zhuravleva E, Carpino G, Overi D, Urretabizkaia-Garmendia J, Labiano I, Korosec A, Val B, Calvisi DF, Ilyas SI, den Haan JMM, Aspichueta P, Hijona E, La Casta A, Jiménez-Agüero R, Lleo A, Macias RIR, Gaudio E, European CCA Histology Registry, Andersen JB, Schabbauer G, Bujanda L, Rodrigues PM, Sharif O, Banales JM, Perugorria MJ

Open source

DOI
10.1038/s41392-026-02657-w
Published
2026 Apr 29
Container
Signal transduction and targeted therapy
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41392-026-02657-w,
  title = {MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.},
  author = {Agirre-Lizaso A and Huici-Izagirre M and O'Rourke CJ and Zhuravleva E and Carpino G and Overi D and Urretabizkaia-Garmendia J and Labiano I and Korosec A and Val B and Calvisi DF and Ilyas SI and den Haan JMM and Aspichueta P and Hijona E and La Casta A and Jiménez-Agüero R and Lleo A and Macias RIR and Gaudio E and European CCA Histology Registry and Andersen JB and Schabbauer G and Bujanda L and Rodrigues PM and Sharif O and Banales JM and Perugorria MJ},
  year = {2026},
  journal = {Signal transduction and targeted therapy},
  doi = {10.1038/s41392-026-02657-w},
  url = {https://doi.org/10.1038/s41392-026-02657-w}
}

RIS

TY  - JOUR
TI  - MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.
AU  - Agirre-Lizaso A
AU  - Huici-Izagirre M
AU  - O'Rourke CJ
AU  - Zhuravleva E
AU  - Carpino G
AU  - Overi D
AU  - Urretabizkaia-Garmendia J
AU  - Labiano I
AU  - Korosec A
AU  - Val B
AU  - Calvisi DF
AU  - Ilyas SI
AU  - den Haan JMM
AU  - Aspichueta P
AU  - Hijona E
AU  - La Casta A
AU  - Jiménez-Agüero R
AU  - Lleo A
AU  - Macias RIR
AU  - Gaudio E
AU  - European CCA Histology Registry
AU  - Andersen JB
AU  - Schabbauer G
AU  - Bujanda L
AU  - Rodrigues PM
AU  - Sharif O
AU  - Banales JM
AU  - Perugorria MJ
PY  - 2026
JO  - Signal transduction and targeted therapy
DO  - 10.1038/s41392-026-02657-w
UR  - https://doi.org/10.1038/s41392-026-02657-w
ER  - 

APA

A, A., M, H., CJ, O., E, Z., G, C., D, O., J, U., I, L., A, K., B, V., DF, C., SI, I., JMM, D. H., P, A., E, H., A, L. C., R, J., A, L., RIR, M., E, G., Registry, E. C. H., JB, A., G, S., L, B., PM, R., O, S., JM, B., & MJ, P. (2026). MARCO promotes cholangiocarcinogenesis by inducing immunosuppression and its targeting reduces tumor growth.. Signal transduction and targeted therapy. https://doi.org/10.1038/s41392-026-02657-w

Source records